SurModics, Inc.
SRDX
$30.76
-$0.13-0.42%
| Weiss Ratings | SRDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | D | |||
| Rating Factors | SRDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SRDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.22 | |||
| Price History | SRDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.12% | |||
| 30-Day Total Return | -10.35% | |||
| 60-Day Total Return | -22.17% | |||
| 90-Day Total Return | -21.51% | |||
| Year to Date Total Return | -22.48% | |||
| 1-Year Total Return | 14.05% | |||
| 2-Year Total Return | 38.50% | |||
| 3-Year Total Return | -29.79% | |||
| 5-Year Total Return | -9.29% | |||
| 52-Week High % Change | -27.21% | |||
| 52-Week Low % Change | 22.73% | |||
| Price | SRDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $42.44 | |||
| 52-Week Low Price | $25.17 | |||
| 52-Week Low Price (Date) | Apr 30, 2024 | |||
| 52-Week High Price (Date) | Jul 09, 2024 | |||
| Valuation | SRDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 441.60M | |||
| Enterprise Value | 444.49M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.03 | |||
| Earnings Per Share Growth | -366.89% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.50 | |||
| Price/Book (Q) | 3.95 | |||
| Enterprise Value/Revenue (TTM) | 3.54 | |||
| Price | $30.76 | |||
| Enterprise Value/EBITDA (TTM) | 66.94 | |||
| Enterprise Value/EBIT | -246.39 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | SRDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 14.23M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SRDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 952 500 7000 | |||
| Address | 9924 West 74th Street Eden Prairie, MN 55344-3523 | |||
| Website | www.surmodics.com | |||
| Country | United States | |||
| Year Founded | 1979 | |||
| Profitability | SRDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1.43% | |||
| Profit Margin | -11.48% | |||
| Management Effectiveness | SRDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -0.66% | |||
| Return on Equity | -- | |||
| Income Statement | SRDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 125.45M | |||
| Total Revenue (TTM) | 125.45M | |||
| Revenue Per Share | $8.82 | |||
| Gross Profit (TTM) | 93.52M | |||
| EBITDA (TTM) | 6.64M | |||
| EBIT (TTM) | -1.80M | |||
| Net Income (TTM) | -14.41M | |||
| Net Income Avl. to Common (TTM) | -14.41M | |||
| Total Revenue Growth (Q YOY) | -2.06% | |||
| Earnings Growth (Q YOY) | -364.50% | |||
| EPS Diluted (TTM) | -1.03 | |||
| EPS Diluted Growth (Q YOY) | -333.33% | |||
| Balance Sheet | SRDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 30.15M | |||
| Cash Per Share (Q) | $2.12 | |||
| Total Current Assets (Q) | 71.85M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 111.77M | |||
| Current Ratio (Q) | 5.449 | |||
| Book Value Per Share (Q) | $7.82 | |||
| Total Assets (Q) | 163.74M | |||
| Total Current Liabilities (Q) | 13.19M | |||
| Total Debt (Q) | 33.03M | |||
| Total Liabilities (Q) | 51.97M | |||
| Total Common Equity (Q) | 111.77M | |||
| Cash Flow | SRDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 9.23M | |||
| Cash from Financing (TTM) | -3.10M | |||
| Net Change in Cash (TTM) | 6.79M | |||
| Levered Free Cash Flow (TTM) | 9.92M | |||
| Cash from Operations (TTM) | 1.15M | |||
